why choose us

First received: February 03, 2023

Clinical Trial: Satralizumab in Aneurysmal Subarachnoid Hemorrhage

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Aneurysmal Subarachnoid Hemorrhage

Study Type: INTERVENTIONAL


Official Title: A Phase 1 Clinical Trial of Satralizumab as a Treatment for Aneurysmal Subarachnoid Hemorrhage

Brief Summary: In this study, satralizumab will be administered to see whether satralizumab is safe in patients with a burst brain aneurysm and if it may prevent strokes in patients with a burst brain aneurysm.

Read more